Novavax, Inc. (NVAX)

Novavax Revenue

Novavax had revenue of $139.51M in the quarter ending March 31, 2026, a decrease of -79.07%. This brings the company's revenue in the last twelve months to $596.34M, down -52.48% year-over-year. In the year 2025, Novavax had annual revenue of $1.12B with 64.69% growth.

• Revenue (ttm): $596.34M
• Revenue Growth: -52.48%
• P/S Ratio: 2.56
• Revenue / Employee: $796,179
• Employees: 749
• Market Cap: 1.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.12B	441.32M	64.69%
Dec 31, 2024	682.16M	-301.54M	-30.65%
Dec 31, 2023	983.71M	-998.17M	-50.36%
Dec 31, 2022	1.98B	835.58M	72.89%
Dec 31, 2021	1.15B	670.69M	141.02%
Dec 31, 2020	475.60M	456.94M	2,448.48%
Dec 31, 2019	18.66M	-15.63M	-45.57%
Dec 31, 2018	34.29M	3.11M	9.98%
Dec 31, 2017	31.18M	15.82M	103.06%
Dec 31, 2016	15.35M	-20.90M	-57.65%
Dec 31, 2015	36.25M	5.59M	18.24%
Dec 31, 2014	30.66M	9.74M	46.59%
Dec 31, 2013	20.92M	-1.16M	-5.26%
Dec 31, 2012	22.08M	7.39M	50.30%
Dec 31, 2011	14.69M	14.35M	4,182.22%
Dec 31, 2010	343.00K	18.00K	5.54%
Dec 31, 2009	325.00K	-739.00K	-69.45%
Dec 31, 2008	1.06M	-449.00K	-29.68%
Dec 31, 2007	1.51M	-225.00K	-12.95%
Dec 31, 2006	1.74M	-3.61M	-67.47%
Dec 31, 2005	5.34M	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error